We applied the fluorescent DNA stains diamidino yellow (DY) and chromomycin A3 to rat and rabbit retinas in vivo and in vitro. They accumulated in the nuclei of a subpopulation of cells of the inner nuclear layer. The number and distribution of the fluorochrome-accumulating cells were similar to those of the Miiller glia, and double-labeling experiments showed that the cells accumulating DY or chromomycin A3 contained oriented filaments of vimentin. The fluorochromes also accumulated in the sparse astrocytes and oligodendrocytes located among the myelinated fibers of the rabbit central retina. Specific accumulation in retinal glia occurred only when the fluorochromes were applied to liv-ing retinas. Ifthe plasma membranes were disrupted by fiation or exposure to detergent, most retinal cells wwe stained. This indicates that the locus of specificity is the entry of the molecules into the ells. When applied to living retinas, other DNA stains selectively accumulate in subclasses of retinal neurons. Why DNA-binding molecules should selectively cross the membranes of either retinal neurons or retinal glia remains an unsolved problem. ( J Hisrochem Cyrochem
Introduction
Fluorescent compounds that bind nucleic acids can be used as nuclear stains, making individual cells visible even in tissues, such as brain, that have little extracellular matrix. They have been particularly useful in the retina. Acridine orange, which binds to nucleic acids in all cells, is presently used to render living retinal neurons visible for microinjection Uensen, 1991; Dacey, 1989; Vardi et al., 1989; Tauchi and Masland, 1985) . The AT-specific probe DAPI (4,6-diamidino-2-phenylindole) is more specific: when applied to living retinas it accumulates preferentially in the nuclei of amacrine cells, with a further specificity among amacrine cell subclasses (Voight, 1986; Masland et al., 1984; Euchi and Masland, 1984; Masland, 1983; Hayden et al., 1980) . Nuclear yellow (2 -[4-sulfamylphenyl]-6-[ 6-(4-methylpiperazino)-2-benzimidatolyl] benzimidazole trihydrochloride) shows a similar pattern but with preference for other subclasses of amacrine cells (Vaney et al., 1991; Masland, 1983) . The mechanism of the specificity is not known.
Here we report that two DNA-binding molecules accumulate selectively in retinal glia. One is diamidino yellow (DY), a chemical variant of DAPI widely used for tracing axonal pathways. After injection into a brain region, DY is retrogradely transported by nearby axons, eventually accumulating in the nuclei of parent cell bodies (Haase and Payne, 1990; Conde, 1987; Kuypers and Huisman, 1984; Keizer et al., 1983) . DY has apparently not been used as a topical probe, although anecdotal comments in studies of retrograde transport suggest that it accumulates in glial cells around the injection site (Conde, 1987; Keizer et al., 1983) .
The second is chromomycin A3, which is used for chromosome labeling. Chromomycin A3 binds selectively to GC-rich DNA (Banville et al., 1990) . At one time chromomycin A3 was thought to selectively label dividing cells Uensen, 1977) . Its main use at present is for chromosome marking, especially in conjunction with flow cytometry (Bartholdi et al., 1989; Engh et al., 1988; Darzynkiewicz et al., 1984; Langlois et al., 1982) .
DY and chromomycin A3 provide an alternative to immunohistochemistry for distinguishing retinal glia from neurons. Because the differential accumulation is striking, they also raise in a particularly clear way the question of why living cells differentially accumulate DNA-binding molecules.
Materials and Methods
Adult New Zealand Red or New Zealand White rabbits and adult Long-Evans rats were used for these experiments. Animals were anesthetized with a mixture ofketamine hydrochloride (30-40 mg/kg) and xylazine (3-6 mg/kg).
Proparacaine HCI (200-300 PI) was applied to the cornea to suppress blink reflexes. Diamidino yellow dihydrochloride (Sigma; St Louis, MO) and chromomycin A3 (Sigma) were solubilized with 100% ethanol (1 mg com-1651 pound/2 ml ethanol). For DY, 200 p1 of ethanol solution was added to 100 p1 of a solution of 10% Phonic F-127 (Molecular Probes; Eugene, OR) in dimethylsulfoxide (Sigma). (Detergent was used because the solubility of DY in water is limited. To control for the effects of these solvents, we partially dissolved DY in water; injecting the suspension into the eye yielded the same retinal staining as when detergent was used.) Rabbits received 10-30 p1 of the final solution (5-10 pg of DY or chromomycin A3) into the vitreous body from a 25-pI microsyringe (22s-gauge needle) (Hamilton; Reno, NV). These amounts were chosen on the basis of previous studies of retinal labeling by DNA-binding molecules. In general, the concentration dependence of the labeling is not steep, with the same results obtained over a concentration range of one to two orders of magnitude. The higher concentrations yield brighter staining and somewhat more background, but the specificity of labeling is preserved ; and in vitro experiments described below). The animals appeared to experience no discomfort on awakening and no generalized toxic reactions were observed. Rabbits survived for 1-4 days before eye enucleation. Rats received 1-3 pl of the final solution (0.5-1 clg of DY or chromomycin A3) intraocularly, and survived for 1-2 days. The animals were then reanesthetized and the retinas were isolated from the eye by methods described elsewhere (Ames and Masland, 1990) . Retinas were fixed for 1-2 hr with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) with 0.002% CaClz added to preserve cell membranes.
Other retinas were isolated without any intraocular exposure to fluorochromes and were maintained in vitro; they were exposed to DY or chromomycin A3 (0.4, 4, 10, and 40.pgl6ml Ames medium) for 30-40 min and then fixed and processed as above. Specific staining was observed at all concentrations. Some eyes did not receive intraocular DY or chromomycin A3; the retinas were fixed with the same fixative for 1-2 hr and then incubated for 3-6 hr in DY or chromomycin A3 in Ames medium (Sigma) or 0.25 M Xis buffer (5-10 pg of DY or chromomycin A3 in 1.5 ml solution). After several rinses with 0.25 M Tris buffer, whole retinas were mounted flat and coverslipped with Aquamount (Lener Lab; Pittsburgh, PA), 100% glycerol (Mallinckrodt; Paris, KY), JB4 (Polysciences; Warrington, PA), Krystalon (EM Diagnostic Systems; Gibbstown, NJ), Permount (Fisher; Fairlawn, NJ), SlowFade (Molecular Probes), or Vectorshield (Vector; Burlingame, CA).
Three kinds of double-labeling experiments were carried out. In all cases the retinas were labeled as usual by intraocular injection of DY or chromomycin A3. Small pieces of fixed retina were embedded in 4% agar (Sigma). The retinas were cut either vertically or horizontally in 25-pm thick sections with a vibratome. The sections were then processed free floating in small vials. Tissue sections were reacted at room temperature with gentle agitation. Immunohistochemistry was carried out as follows.
To identify Muller cells, sections were reacted with monoclonal antibody directed against vimentin (Sigma; clone 9). Primary antibody was used at 1:40 in 4% normal horse serum in 0.25 M Tris buffer (pH 7.4) for 16-20 hr. Secondary was fluorescein or Texas red anti-mouse (Vector) at 1:25 dilution in 4% normal horse serum in 0.25 M Tris for 2-4 hr.
To identify astrocytes, sections were incubated with polyclonal antibody directed against glial fibrillary acidic protein (GFAP) (Sigma). Primary antibody was used at 1:100 in 4% normal goat serum in 0.25 M Tris. Secondary was fluorescein or Texas red anti-rabbit IgG at 1:25 dilution in 4% normal goat serum for 2-4 hr.
To identify oligodendrocytes, sections were reacted with antibodies directed against galactocerebroside (provided by Dr. B. Rauscht) (Rauscht et al., 1982) . Primary antibody was used at 1:2 dilution in 4% normal horse serum in Eis. Secondary was fluorescein or Texas red anti-mouse IgG at 1:25 dilution in 4% normal horse serum for 2-4 hr.
In some cases the primary antibody reaction was followed by incubation with a 1:200 dilution of biotinylated secondary IgG. Tissues with biotinylated IgG were finally incubated with 1:50-100 dilution of fluorescence (fluorescein, Texas red, or 7-amino-4-methylcoumarin-3-acetic acid)-conjugated avidin D or avidin DCS (Vector) for 2-4 h. The two-step procedure took several hours less and was advantageous when migration of the DNA stains was a possibility (see Results). The three-step procedure was more sensitive.
Some sections were counterstained with ethidium homodimer (Molecular Probes). They were stained for 30 min with 4 pM ethidium homodimer in 0.1 M phosphate buffer (pH 7.4). Tissue sections were rinsed in multiple changes of Eis buffer between each step. They were mounted with either SlowFade or Vectorshield. Tissues labeled with fluorescent compounds were examined on a Leitz Dialux 20 microscope using Leitz filter set A (excitation 340-380 nm), H2 (390-490 nm), or N2 (530-560 nm) or the Omega F I X (466-493 nm) filter set.
The density of Miiller cells (Figure 3 ) was estimated by counting them from micrographs of stained whole mounts. The retina was prepared by intraocular injection of DY. It was fixed in 4% paraformaldehyde and mounted flat. Two short coverslips were placed at the ends of a standard microscope slide. The tissue was carefully placed between them and wetted with glycerol. A coverslip was then placed over the tissue. Bridging the coverslip in this way prevents pressure of the coverslip on the tissue. (kghtly fixed retains can spread laterally under the pressure of a coverslip; the effect on the density of cells is great because a small linear spreading results in a larger area increase.) Sample fields were photographed at 1-mm intervals beginning at the ventral edge of the tissue sample and extending to the region of the myelinated fiber bundles.
Results
The primary accumulation of DY after application to the living retina was in a subgroup of cells in the inner nuclear layer ( Figure  1A) . Ganglion cells accumulated the fluorochrome, but faintly. Within the cells DY appeared almost exclusively bound to nuclei. Seen in whole mounts the nuclei were round or slightly oval ( Figures  1A and 2A) . The fluorochrome was widely distributed within the nuclei. The results were the same in rabbit and rat.
The number of nuclei labeled by DY was established by counting them in a rabbit retina prepared as a whole mount. Measurements were made along a strip running from the ventral periphery to the optic fiber bundles along an axis 3 mm lateral to the optic nerve head. The density peaked at about 14,600 nuclei/mm2 in the visual streak and fell to roughly 10,200 nuclei/mm2 in the ventral periphery (Figure 3) . These densities fell within the range expected for Muller cells. In addition, the stained cells' distribution across the retina had the relatively flat contour characteristic of Miiller cells, which are less strongly concentrated in the central retina than are the inner retinal neurons (Robinson and Dreher, 1990) .
We therefore carried out double-labeling experiments in which DY was injected intraocularly and sections were subsequently reacted with antibodies against vimentin. The cells of the inner nuclear layer that accumulated DY were exclusively vimentin positive (Figure 4) . Vimentin is found in strands that extend the length of the very similar to that of DY, and the population of nuclei had identical size and spacing (Figures 1B and 2B) . Chromomycin A3 lightly accumulated in photoreceptor cell nuclei. (When inspected in the microscope, the photoreceptor labeling faded quickly; this was accompanied by a shift of the emitted light towards longer wavelengths.) Chromomycin A3 did not accumulate in the nuclei of ganglion cells. The pattern of accumulation was the same in the rabbit and rat (Figures 1B and 2B) .
With chromomycin A3, but not DY, a population of fluorescent nuclei with deviant properties was seen. When the tissue was viewed as a whole mount, a subset of the stained nuclei appeared smaller and brighter than the others (Figures 1B and 2B) . The small bright profiles were usually round, but a subset had irregular shapes. These nuclei were often present within gaps in the regular mosaic of fluorescent nuclei, such that a brightly stained element was encircled by nuclei showing the more usual density of staining. These nuclei were apparently pyknotic. Muller cell injury would not be surprising in response to chronic treatment of the retina with chromomycin A3. an agent known to be cytotoxic (Nork et al., 1986; Gupta, 1982 ; Rentsch. 1973 ).
Accumulation of DY and Cbromomycin A3 in Otber Retinal Glia
The rabbit retina is unusual in that optic nerve fibers become my- ONL fibers (the medullary rays) contains the astrocytes and oligodendrocytes. When DY or chromomycin A3 was applied to the living tissue, accumulation in the nuclei of cells located within the medullary rays was observed. Sections were reacted for glial fibrillary acidic protein, a marker for astrocytes (Schnitzer, 1988) , or for galactocerebroside, a marker for oligodendrocytes (Raff et al., 1978) . Figure 5 shows co-localization of DY and GFAP in astrocytes. In the medullary rays, DY-accumulating nuclei had an elongated shape and were aligned along the axis of the optic nerve axons. Double labeling with GFAP showed many of them to be astrocytes. Figure  6 shows DY accumulation in the nuclei of oligodendrocytes. Staining for galactocerebroside was evident in thin filaments along the optic fibers and in a rim around the somata of some of the DYlabeled cells.
In Vivo, In Vitro, and Post-mortem Labeling
A convenient way to expose living retinas to the probes was by intraocular injection 1-2 days before sacrifice. However, similar results were obtained when the retina was removed and maintained in the living state in vitro for 30-40 min (Figure 7) . There was slightly more background fluorescence after in vitro labeling, perhaps because a higher concentration of DY or chromomycin A3 was needed to achieve bright labeling in a short time. In contrast, application of these probes to fixed tissue yielded nonspecific binding patterns. When the retina was fixed with aldehydes and then exposed without sectioning to DY or chromomycin A3, nuclei in the ganglion cell and outer nuclear layers were labeled first, apparently reflecting the probes' inward diffusion. Within the outer nuclear layer there was a gradient of labeling intensity, with nuclei in the superficial parts more intense than those located deeper. Application of DY to vertical sections labeled every nucleus in the section, with little variation of intensity among them.
Neither DY nor chromomycin A3 binds covalently to DNA, and t h i s was reflected in their behavior during histological processing. Retinas labeled in the living state could be fixed without initial loss of specificity. Under some conditions the probes subsequently migrated to nuclei other than those of the glia. When the intact tissue was exposed to 0.4% Triton X-100, as during routine immunohistochemistry, the probes were subsequently found to be bound almost uniformly to all retinal nuclei. When tissues were embedded in agar, sectioned, and mounted under buffer, the probes migrated within the sections and within a few days many nuclei were labeled. During dehydration and embedding in methacrylate there was some migration, but the glial nuclei remained much brighter than the others. Methacrylate sections mounted in plastic (Krystalon) showed stable localization of the probes. Whole mounts or agar-embedded tissue retained stable cell labeling for at least 4 months when covenlipped under Krystalon or 100% glycerol. In Aquamount. SlowFade, or Vectonhield migration of the probes was substantial within 2-3 days. 
Discussion
When applied to living retina, DY and chromomycin A3 accumulated in the nuclei of glial cells. These included the astrocytes and oligodendrocytes present near the surface of the retina (among the optic fibers) in the retina's central-most region. By far the major class, however. was the Muller glia. which are present throughout the retina and are its predominant glial cell. t DY and chromomycin A3 may have practical uses as markers for the Muller glia. The staining is robust and yields high contrast.
Its practical advantages are that it requires no further processing, provides flexibility for double-labeling experiments, and can be used in living tissue. DY and chromomycin A3 both penetrate the tissue readily, thus providing a convenient alternative to the use of immunohistochemistry in whole mounts, which is limited because of the tissue thickness. It is possible that systemic or intraventricular application of these molecules would afford a marker for glial cells in the brain.
Although the ability to stain living tissue is a useful feature under some circumstances, it is also a limitation: these probes apparently cannot be used as routine stains for glia in post-mortem material. Furthermore, the binding is not stable during treatment of the tissue with detergent. This limits the use of DY or chromomycin A3 in combination with immunohistochemistry to cases (such as the one demonstrated here for vimentin) in which aggressive opening of the cell membranes is not necessary.
It is curious that these DNA-binding molecules accumulate selectively in retinal glia. The probes finally accumulate in the nucleus, as would be expected. Since all the cells have the same DNA, why do DY and chromomycin A3 not stain all retinal cells equally? The problem is similar to one raised by earlier work: other DNA stains accumulate selectively within subclasses not of glia but of neurons. An example is DAPI, which accumulates in amacrine cells (Vaney et al., 1991; Masland et al., 1984) . The specificity is not due to the location of amacrine cells within the tissue, because bright and dim cells are intermixed in the inner nuclear layer. It is not due to cell size or surface area: the ganglion cells are larger than the amacrines and the photoreceptor cells are smaller, yet these cells are less stained than the amacrines. As for the glial markers described here, specificity appears to reside at the level of entry of the fluorescent probe into the cell. If the plasma membrane is opened, DAPI accumulates almost equally in the nuclei of all retinal cells.
The situation is even clearer for chromomycin A3 and DY, because the difference between the cells that accumulate the probe and those that do not is so great (Figures 1 and 2) and because these dyes distinguish a major cell class (glia) from another (neurons). The difference between cells is apparently due to an event or structure specific to the individual fluorochromes. Different amounts of endocytosis, for example, would simply cause the rapidly endocytosing cells to accumulate whatever fluorochrome was available in the extracellular space. Chromomycin A3 might well be exported from some cells by the multidrug-resistance pump (Gottesman and Pastan, 1988) , and a scenario can be constructed in which the retinal neurons have more of the pump than the glia. (The neurons, which must last for the animal's lifetime, would need to be more strongly defended than the glia, which can divide.) However, the multidrug-resistance pump is not present in notably high amounts in the brain (Cordon-Cardo et al., 1990; Fojo et al., 1987) . Since it is assumed that the phospholipid bilayer is roughly similar for all cells, differences in lipid solubility seem an unlikely explanation. What remain are the cells' channels and pores, which are known to vary among neurons and between neurons and glia. Possibly the fluorochromes enter through one or more of them, at rates that are different for different fluorochromes and membrane proteins in different cells.
